Neurology Devices Market Trends

Neurology Devices Market size was valued at USD 15.76 Billion in 2023 and is poised to grow from USD 17.04 Billion in 2024 to USD 31.77 Billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

Neurology devices manufacturers should focus on making their products more affordable to increase their sales potential. Entering developing and underdeveloped countries should also be a priority for neurovascular devices companies going forward. The incorporation of advanced technologies to improve the capabilities of neurovascular devices will also be a key trend for new as well as established neurology devices market players. Investing in research will be a strategy that no neurovascular devices company should skip going forward.  'Medtronic (US)', 'Abbott Laboratories (US)', 'Boston Scientific Corporation (US)', 'Koninklijke Philips N.V. (Netherlands)', 'Siemens Healthineers AG (Germany)', 'Stryker Corporation (US)', 'GE Healthcare (US)', 'Johnson & Johnson (US)', 'Zimmer Biomet Holdings, Inc. (US)', 'Nihon Kohden Corporation (Japan)', 'Hitachi, Ltd. (Japan)', 'Brainlab AG (Germany)', 'Elekta AB (Sweden)', 'LivaNova PLC (UK)', 'Nevro Corp. (US)', 'Natus Medical Incorporated (US)', 'Penumbra, Inc. (US)', 'Integra LifeSciences Holdings Corporation (US)', 'Terumo Corporation (Japan)', 'Neuropace, Inc. (US)'

Poor lifestyle choices and growing adoption of unhealthy habits have significantly increased the number of people suffering from neurovascular diseases. This surge in incidence of neurovascular issues such as strokes and cerebral aneurysms around the world is a key factor promoting neurovascular device demand. An aging global population is increasing the demand for neurological devices, as older people are more likely to suffer from neurological and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and dementia with increasing age and complications the prevalence of age-related forms requiring primary neurologic care. This demographic shift is particularly evident in places like North America, Europe, and parts of Asia, where a growing aging population is putting tremendous pressure on healthcare systems to deliver go-to solutions provide late diagnostic, medical and neurological services. 

Advances in Neurostimulation Technology: One of the most important market trends is the development of neurostimulation technologies. These devices are used to deliver electrical impulses to specific areas of the brain or nerves to treat chronic pain, epilepsy, Parkinson's disease, and dementia. Deep brain stimulation (DBS) and spinal cord stimulators (SCS) alleviate symptoms, improve quality of life and offer less invasive solutions. Neurostimulation devices with innovative features that have precision, connectivity, and battery life for interference are becoming increasingly popular with patients and healthcare professionals. 

North America is the dominating region in the neurology devices industry. The presence of a developed healthcare infrastructure, high healthcare spending potential, and easy availability of advanced neurovascular devices are forecasted to be key factors contributing to the dominance of this region. The United States is slated to be the most opportune market in this region owing to high prevalence of ischemic strokes. Canada is also estimated to provide lucrative opportunities for neurovascular devices companies in this region. Favorable reimbursement and high investments medical research are also expected to help North America maintain its dominance.